Max Robotics — Global Service Robot Directory + US Certification

About

Sung Gu Kang is a urological surgeon and researcher whose work centers on minimally invasive surgical oncology, with a particular focus on robot-assisted radical cystectomy (RARC) for bladder cancer. His early contributions helped establish the feasibility of RARC with extended pelvic lymph node dissection, a technically demanding procedure that his 2009 study demonstrated could be performed safely and effectively even during a surgeon's initial experience with the technique. This foundational work, which has garnered citations in the field, helped pave the way for broader adoption of robotic approaches in bladder cancer surgery. Building on this foundation, Kang has expanded his research to evaluate intermediate and long-term oncologic outcomes through large-scale multicenter investigations. His 2017 multicenter Korean study, drawing on 346 patients across institutions, provided meaningful insight into recurrence patterns and predictive factors following RARC — offering clinicians data to better stratify patient risk. More recently, his 2024 work examining the impact of preoperative smoking history on surgical outcomes reflects a commitment to understanding modifiable risk factors in bladder cancer management. Together, Kang's body of work reflects a career dedicated to refining robotic urological surgery and improving evidence-based care for bladder cancer patients across Korea and beyond.